The death rate of sepsis is high, exceeding 30%, because of the poor understanding of the disease. Sepsis induces profound lymphocyte apoptosis, 2 which keeps adaptive immunity in check, but excessive lymphocyte apoptosis causes immunosuppression in the later stage of sepsis, resulting in susceptibility to secondary infections. Thymocyte apoptosis is a major mechanism of lymphocyte depletion in sepsis; however, how this process is regulated remains poorly understood. [2] [3] [4] Scavenger receptor BI (SR-BI or Scarb1) is a well-characterized high-density lipoprotein (HDL) receptor mainly expressed in the liver and steroidogenic tissues. 5-11 It regulates HDL cholesterol content through reverse cholesterol transport in which SR-BI selectively uptakes cholesteryl ester from HDL. 9,10 Despite a 2-fold increase in plasma HDL cholesterol concentrations, SR-BI −/− mice are susceptible to atherosclerosis. [12] [13] [14] [15] [16] Several earlier studies have shown that SR-BI deficiency leads to larger HDL with a profound increase in unesterified cholesterol concentrations on HDL, 17-20 which may render HDL dysfunctional in SR-BI −/− mice. [21] [22] [23] [24] In support of this notion, an earlier study showed that HDL from SR-BI −/− mice loses activity of selective cholesteryl ester uptake 19 ; several reports suggest that accumulation of unesterified cholesterol on HDL contributes to female infertility and disrupts red blood cell development [21] [22] [23] [24] ; we recently reported that HDL from SR-BI −/− mice also loses activity of suppressing lymphocyte proliferation. 25 Although it has been recognized for years that HDL has immune regulatory activity, how Objective-Thymocyte apoptosis is a major event in sepsis; however, how this process is regulated remains poorly understood. Approach and Results-Septic stress induces glucocorticoids production which triggers thymocyte apoptosis. Here, we used scavenger receptor BI (SR-BI)-null mice, which are completely deficient in inducible glucocorticoids in sepsis, to investigate the regulation of thymocyte apoptosis in sepsis. Cecal ligation and puncture induced profound thymocyte apoptosis in SR-BI +/+ mice, but no thymocyte apoptosis in SR-BI −/− mice because of lack of inducible glucocorticoids. Unexpectedly, supplementation of glucocorticoids only partly restored thymocyte apoptosis in SR-BI −/− mice. We demonstrated that high-density lipoprotein (HDL) is a critical modulator for thymocyte apoptosis. SR-BI +/+ HDL significantly enhanced glucocorticoid-induced thymocyte apoptosis, but SR-BI −/− HDL had no such activity. Further study revealed that SR-BI +/+ HDL modulates glucocorticoid-induced thymocyte apoptosis via promoting glucocorticoid receptor translocation, but SR-BI −/− HDL loses such regulatory activity. To understand why SR-BI −/− HDL loses its regulatory activity, we analyzed HDL cholesterol contents. There was 3-fold enrichment of unesterified cholesterol in SR-BI −/− HDL compared with SR-BI +/+ HDL. Normalization of unesterified cholesterol in SR-BI −/− HDL by probucol administration or lecithin cholesteryl acyltransferase expression restored glucocorticoid-induced thymocyte apoptosis, and incorporating unesterified cholesterol into SR-BI +/+ HDL rendered SR-BI +/+ HDL dysfunctional. Using lckCre-GR fl/fl mice in which thymocytes lack cecal ligation and puncture-induced thymocyte apoptosis, we showed that lckCre-GR fl/fl mice were significantly more susceptible to cecal ligation and puncture-induced septic death than GR fl/fl control mice, suggesting that glucocorticoid-induced thymocyte apoptosis is required for protection against sepsis. Conclusions-The findings in this study reveal a novel regulatory mechanism of thymocyte apoptosis in sepsis by SR-BI and HDL. (Arterioscler Thromb Vasc Biol. 2014;34:966-975 .) The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
HDL regulates immunity and the role of SR-BI in the process remain largely unknown.
In this study, we report a novel function of HDL, namely, modulation of thymocyte apoptosis in sepsis. We demonstrate that SR-BI +/+ HDL enhances glucocorticoid-induced thymocyte apoptosis via promoting glucocorticoid receptor translocation, but SR-BI −/− HDL loses such regulatory activity. We further demonstrate that excessive accumulation of unesterified cholesterol on SR-BI −/− HDL likely renders it dysfunctional. Our findings reveal a novel regulatory mechanism of thymocyte apoptosis by SR-BI and HDL in sepsis.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

SR-BI Is a Key Determinant of Thymocyte Apoptosis in Sepsis
We induced sepsis with cecal ligation and puncture (CLP) in SR-BI +/+ and SR-BI −/− mice and assessed thymocyte apoptosis 18 hours after CLP. Compared with sham, CLP caused significant thymic involution in SR-BI +/+ mice, as shown by a 80% reduction in thymus cell number, but only a slight decrease in thymus cell number in SR-BI −/− mice ( Figure 1A ). Trypan blue assay revealed a marked thymocyte death in CLP-SR-BI +/+ mice, but much less thymocyte death in CLP-SR-BI −/− mice ( Figure 1B ). Clear DNA ladders were observed in CLP-SR-BI +/+ mice, but not in CLP-SR-BI −/− mice ( Figure 1C ). Fluorescence-activated cell sorter analyses indicated profound thymocyte apoptosis in CLP-SR-BI +/+ mice as shown by 22% TUNEL + thymocytes, whereas thymocyte apoptosis was almost completely absent in CLP-SR-BI −/− mice ( Figure 1D and 1E). Hematoxylin and eosin staining showed significant apoptotic cell death in the thymic cortex of CLP-SR-BI +/+ mice, but no apoptotic cell death in CLP-SR-BI −/− mice ( Figure 1F and Figure 
SR-BI Controls Inducible Glucocorticoid Generation in Response to Septic Stress, Which Is a Determinant of Thymocyte Apoptosis in Sepsis
In the early stage of sepsis, adrenals produce high levels of glucocorticoids that trigger thymocyte apoptosis. [2] [3] [4] SR-BI is highly expressed in the adrenals. As an HDL receptor, SR-BI mediates the uptake of cholesteryl ester from HDL for glucocorticoid synthesis, and several studies have shown that SR-BI −/− mice have impaired glucocorticoid production in response to stress. [26] [27] [28] To understand how SR-BI regulates thymocyte apoptosis, we measured plasma corticosterone concentrations in the early stages of sepsis. As early as 2 hours after CLP challenge, SR-BI +/+ mice produced high concentrations of corticosterone, but SR-BI −/− mice failed to upregulate glucocorticoids in response to septic stress (Figure 2A ), which is consistent with our earlier report. 26 Given the essential role of glucocorticoids in triggering thymocyte apoptosis, [2] [3] [4] we reasoned that the lack of SR-BImediated inducible glucocorticoid (iGC) generation accounts for the impaired thymocyte apoptosis in sepsis. To test this, we administered dexamethasone to SR-BI +/+ and SR-BI −/− mice, expecting that supplementation of glucocorticoids would restore glucocorticoid-induced apoptosis in SR-BI −/− mice. Dexamethasone administration induced profound thymocyte apoptosis in SR-BI +/+ mice as shown by DNA ladders and a marked increase in TUNEL + cell percentage ( Figure 2B and 2C). Unexpectedly, dexamethasone administration only partly restored thymocyte apoptosis in SR-BI −/− mice as shown by a lack of clear DNA ladders and 2-fold fewer TUNEL + cell percentages in SR-BI −/− mice ( Figure 2B and 2C). Taken together, these findings not only indicate that SR-BI controls iGC generation in sepsis, but also imply that SR-BI modulates thymocyte apoptosis via an unidentified mechanism in addition to simply controlling iGC generation.
SR-BI Regulates Thymocyte Apoptosis Independent of Its Expression on Thymocytes
SR-BI is moderately expressed in the thymus ( Figure IIA in the online-only Data Supplement). Our earlier study demonstrated that SR-BI induces apoptosis on serum depletion in vitro. 29 This raised the possibility that SR-BI may regulate thymocyte apoptosis intrinsically. To test this, we isolated thymocytes from SR-BI +/+ and SR-BI −/− mice, incubated the cells with corticosterone, and monitored cell death. SR-BI +/+ and SR-BI −/− thymocytes displayed similar cell death in response to corticosterone or dexamethasone ( Figure IIB and IIC in the online-only Data Supplement). To exclude an intrinsic effect in vivo, we conducted bone marrow transplantation by transferring SR-BI +/+ or SR-BI −/− bone marrow-derived cells into Rag-1 −/− mice. Rag-1 −/− mice are deficient in CD4 + CD8 + (DP), CD4 + CD8 − , and CD4 − CD8 + (SP) thymocytes ( Figure IIIA in the online-only Data Supplement). Six weeks after bone marrow transplantation, the Rag-1 −/− mice were populated with thymocytes derived from donor mice as shown by the presence of DP and SP thymocytes ( Figure IIIA in the onlineonly Data Supplement). We then conducted CLP on these mice. As shown in Figure IIIB and IIIC in the online-only Data Supplement, CLP induced similar thymocyte apoptosis in mice receiving either SR-BI +/+ or SR-BI −/− bone marrow-derived cells and depleted DP thymocytes equally well in these mice. These findings indicate that SR-BI does not have an intrinsic effect on glucocorticoid-induced thymocyte apoptosis.
HDL Enhances Glucocorticoid-Induced Thymocyte Apoptosis, but HDL From SR-BI −/− Mice Loses Such Regulatory Activity
SR-BI plays an essential role in HDL metabolism. SR-BI −/− mice display abnormal HDL as shown by larger HDL particles associated with a 2-fold increase in HDL cholesterol content. [17] [18] [19] [20] We hypothesized that HDL modulates glucocorticoid-induced thymocyte apoptosis and SR-BI modulates glucocorticoid-induced thymocyte apoptosis via its effect on HDL. To test this hypothesis, we isolated HDL from SR-BI +/+ and SR-BI −/− mice and assessed its effect on glucocorticoid-induced thymocyte apoptosis. We incubated thymocytes isolated from SR-BI +/+ mice with corticosterone in the presence of SR-BI +/+ or SR-BI −/− HDL and quantified thymocyte apoptosis with 7-aminoactinomycin D (7-AAD) staining. As shown in Figure 3A and 3B, corticosterone induced significantly thymocyte apoptosis compared with noncorticosterone treatment in the absence of HDL. Interestingly, HDL from SR-BI +/+ mice significantly enhanced corticosterone-induced thymocyte apoptosis, but HDL from SR-BI −/− mice suppressed corticosterone-induced thymocyte apoptosis ( Figure 3A and 3B). We further tested the dose effect of HDL and found that SR-BI +/+ HDL promotes corticosterone-induced thymocyte apoptosis, but SR-BI −/− HDL suppressed corticosterone-induced thymocyte apoptosis in a dose-dependent manner ( Figure IV in the online-only Data Supplement). In vitro cell apoptosis usually undergoes secondary necrosis because of lack of phagocyte-mediated engulfment of the apoptotic cells. 30, 31 Indeed, we detected a significant increase in necrotic cell death ( Figure 3C ). We also used Trypan blue exclusion to test the effect of . Scavenger receptor (SR)-BI +/+ high-density lipoprotein (HDL) enhances glucocorticoid-induced thymocyte apoptosis through promoting GR translocation, but SR-BI −/− HDL lacks such regulatory activity. A to D, SR-BI +/+ HDL enhances glucocorticoid-induced thymocyte apoptosis, but SR-BI −/− HDL lacks such regulatory activity. Thymocytes harvested from wild-type mice were cultured in complete medium and incubated with/without 10 μmol/L corticosterone in the presence/absence of HDL isolated from SR-BI +/+ (20% vol/vol, 0.345±0.011 mg/mL by protein) or SR-BI −/− (20% vol/vol, 0.310±0.012 mg/mL by protein) for 18 hours and analyzed with 7-aminoactinomycin D (7-AAD) staining (A-C) and with Trypan blue exclusion assays (D). n=4 with duplicate measurements. Similar data were obtained when SR-BI −/− thymocytes were used ( Figure V in the online-only Data Supplement). E to H, Human HDL enhances glucocorticoid-induced thymocyte apoptosis. Thymocytes were incubated with/without 10 μmol/L of corticosterone in the presence/ absence of human HDL (20% vol/vol, 0.168±0.012 mg/mL by protein) and analyzed with 7-AAD staining (E-G) and with Trypan blue exclusion assays (H). n=3 with triplicate measurements. I, SR-BI +/+ HDL promoted glucocorticoid-induced GR translocation, but SR-BI −/− HDL lacked such regulatory activity. L929 cells were incubated with/without 100 nmol/L dexamethasone in the presence/absence of SR-BI +/+ or SR-BI −/− HDL for 15 and 30 minutes. The cytosol and nucleus fractions were isolated, and the GR was detected with Western blot. Tubulin and SP1 were used as the markers of cytosol and nucleus, respectively.
HDL on thymocyte cell death and obtained similar findings ( Figure 3D ). These data suggest that normal HDL promotes glucocorticoid-induced thymocyte apoptosis, but SR-BI −/− HDL loses this regulatory function. Similar results were obtained with dexamethasone incubations (data not shown).
Human HDL Enhances Glucocorticoid-Induced Thymocyte Apoptosis
We isolated HDL from human serum and tested its effect on corticosterone-induced thymocyte apoptosis. Similar to normal mouse HDL, human HDL significantly enhanced glucocorticoid-induced thymocyte apoptosis as shown by 7-AAD staining ( Figure 3E -3G) and Trypan blue exclusion ( Figure 3H ) assays.
HDL Enhances Glucocorticoid-Induced Thymocyte Apoptosis via Promoting GR Translocation, but HDL From SR-BI −/− Mice Loses Such Regulatory Activity
On entering cells, glucocorticoid binds to GR, resulting in GR translocation from cytosol to the nucleus, where GR functions as transcriptional factor to activate apoptotic signaling. To further understand the molecular mechanisms by which HDL modulates glucocorticoid-GR apoptotic signaling, we tested the effects of HDL on GR translocation using L929 cells, a cell line widely used for glucocorticoid-GR signaling. 32 As shown in Figure 3I , GR moved rapidly from cytosol to the nucleus in response to dexamethasone incubation. Importantly, HDL from SR-BI +/+ mice markedly enhanced glucocorticoid-induced GR translocation, but HDL from SR-BI −/− mice suppressed glucocorticoid-induced GR translocation.
Deficiency of HDL In Vivo Impairs Thymocyte Apoptosis in Sepsis
Apoprotein A1 (apoAI −/− ) mice are grossly deficient in HDL ( Figure 4A ) 33 and thus have been used as an HDL-deficient model to determine the roles of HDL in vivo. [34] [35] [36] We used apoAI −/− mice to elucidate the contribution of HDL to thymocyte apoptosis in vivo. On CLP, apoAI −/− mice displayed a 2-fold decrease in the percentage of TUNEL + thymocytes ( Figure 4B ) and less depletion in DP thymocytes compared with C57BL/6J mice ( Figure 4C ). An earlier study indicated that apoAI −/− mice have impaired glucocorticoid production in response to stress, which raised the possibility that apoAI −/− mice might produce less glucocorticoids in sepsis. 37 To exclude such a possible effect, we induced thymocyte apoptosis by administering dexamethasone to apoAI −/− and C57BL/6J mice. As shown in Figure 4D , dexamethasonetreated apoAI −/− mice had significantly fewer TUNEL + thymocytes than dexamethasone-treated C57BL/6J mice. Thus, these observations provided in vivo evidence that HDL modulates glucocorticoid-induced thymocyte apoptosis.
Normalization of the Unesterified Cholesterol Content in SR-BI −/− HDL Restores Its Regulatory Activity of Modulating Glucocorticoid-Induced Thymocyte Apoptosis
SR-BI deficiency leads to larger HDL with a profound increase in unesterified cholesterol ratio of HDL. [18] [19] [20] We analyzed the cholesterol content of these HDL particles. Consistent with the earlier reports, [18] [19] [20] we observed a 3-fold increase in unesterified cholesterol content in HDL, but only marginally increasing in the cholesteryl ester concentrations ( Figure 5A , normal diet). The major form of cholesterol in SR-BI +/+ HDL particles is cholesteryl ester, which is located in the inner core of HDL because of its hydrophobic nature. In contrast, unesterified cholesterol is more hydrophilic and polar and therefore is located on the surface of HDL. 22 Given that earlier studies have shown that the accumulation of unesterified cholesterol in circulation causes female infertility and abnormal red blood cell develops in SR-BI −/− mice, [21] [22] [23] [24] it is likely that the massive accumulation of unesterified cholesterol in SR-BI −/− HDL disrupts the structure of HDL, leading to its dysfunction on regulating thymocyte apoptosis. To test this speculation in vivo, we administered SR-BI +/+ and SR-BI −/− mice with probucol, a cholesterol-lowering drug that has been shown to normalize unesterified cholesterol levels in SR-BI −/− mice. [21] [22] [23] [24] As shown in Figure 5A (probucol diet), probucol administration normalized the unesterified cholesterol content of SR-BI −/− HDL to almost normal levels. When we administered dexamethasone to the probucol-treated mice, we observed a 2-fold increase in the percentage of TUNEL + thymocytes in probucol-treated SR-BI −/− mice compared with untreated SR-BI −/− mice ( Figure 5B ).
We then tested the ability of HDL isolated from the probucol-treated mice to modulate corticosterone-induced thymocyte death. As shown in Figure 5C , HDL isolated from probucol-treated SR-BI −/− mice increased the corticosterone-induced thymocyte death by 3-fold compared with HDL isolated from non-probucol-treated SR-BI −/− mice. Thus, both in vivo and in vitro data indicated that correcting the unesterified cholesterol content of SR-BI −/− HDL restores its ability to modulate thymocyte apoptosis in sepsis.
Incorporation of Free Cholesterol to Normal HDL Renders the HDL Dysfunctional in Modulating Glucocorticoid-Induced Thymocyte Apoptosis
Probucol has functions other than lowering plasma cholesterol. To further support our hypothesis, we took an independent approach by incorporating free cholesterol into SR-BI +/+ HDL following a method described by Cooper et al. 38 Compared with control HDL that was treated with dipalmitory lecithin alone, the HDL treated with free cholesterol/dipalmitoyl lecithin had 3-fold enriched unesterified cholesterol content and a significant increase in the unesterified cholesterol to cholesteryl ester ratio ( Figure 6A ). We tested the effect of this free cholesterol-enriched HDL on glucocorticoid-induced thymocyte apoptosis. The control HDL promoted glucocorticoid-induced thymocyte apoptosis by 2-fold as shown by 7-AAD stainings ( Figure 6B and 6C). However, the free cholesterol-enriched HDL did not promote glucocorticoid-induced thymocyte apoptosis, as shown by only 37% positive 7-AAD stainings in free cholesterol-enriched HDL, versus 70% positive 7-AAD stainings in control HDL ( Figure 6B and 6C) . Similar findings were obtained with Trypan blue exclusion assay ( Figure 6D ). There was no significant difference in glucocorticoid-induced thymocyte apoptosis between SR-BI +/+ HDL without dipalmitory lecithin treatment and control SR-BI +/+ HDL treated with dipalmitory lecithin (Figures 3 and 6 ). Of note, we observed that the SR-BI −/− HDL strongly inhibited glucocorticoid-induced thymocyte apoptosis (Figure 3 ), but the free cholesterol-enriched HDL neither promoted nor inhibited glucocorticoid-induced thymocyte apoptosis ( Figure 6 ). This difference was likely caused by a higher unesterified cholesterol concentration and higher unesterified cholesterol to cholesteryl ester ratio in SR-BI −/− HDL compared with the free cholesterol-enriched HDL. 
Lecithin Cholesteryl Acyltransferase Corrects the Unesterified Cholesterol Content of SR-BI −/− HDL and Restores Its Regulatory Activity on Modulating Glucocorticoid-Induced Thymocyte Apoptosis
An earlier study showed that SR-BI −/− mice have a 90% decrease in endogenous lecithin cholesteryl acyltransferase (LCAT) activity on HDL, 20 Table I in the online-only Data Supplement). Importantly, SR-BI −/− LCAT-tg HDL displayed much higher activity on glucocorticoid-induced thymocyte apoptosis compared with SR-BI −/− HDL ( Figure 7A-7C) .
Collectively, these in vivo and in vitro findings indicate that normal HDL enhances glucocorticoid-induced thymocyte apoptosis through promoting GR translocation, but SR-BI −/− HDL loses this regulatory activity, likely because of disruption of its structure as a result of the accumulation of unesterified cholesterol. To the best of our knowledge, this is the first evidence demonstrating that HDL regulates thymocyte apoptotic signaling in sepsis.
Mice Deficient in Glucocorticoid-GR Signaling in Thymocytes/T Cells Are Susceptible to CLP-Induced Septic Death
We asked whether a deficiency of SR-BI-mediated glucocorticoid-GR signaling in thymocyte/T cells contributes to septic death. Because deficiency of SR-BI-mediated glucocorticoid production will affect glucocorticoid-GR signaling in all types of cells, and glucocorticoid-GR signaling has been shown to play protective roles in macrophages and endothelial cells in sepsis, [39] [40] [41] SR-BI −/− mouse model is not suitable for answering this question. Therefore, we used lckCre-GR fl/fl mice, a model in which glucocorticoid-GR signaling is deficient only in thymocytes/T cells. As expected, lckCre-GR fl/fl mice were completely resistant to CLP-induced thymocyte apoptosis ( Figure 8A and 8B) . Importantly, lckCre-GR fl/fl mice were significantly more susceptible to CLP-induced septic death than GR fl/fl control mice ( Figure 8C) , indicating that the glucocorticoid-GR signaling in thymocytes/T cells is critical for protection against sepsis.
Discussion
The findings in this study reveal a previously unrecognized regulatory mechanism of thymocyte apoptosis in sepsis. We Figure 6 . Incorporation of free cholesterol into normal high-density lipoprotein (HDL) impairs HDL's regulatory activity on glucocorticoid-induced thymocyte apoptosis. A, Incorporation of free cholesterol into normal HDL. Dipalmitory lecithin was sonicated with/ without free cholesterol in saline and then incubated with mouse serum for 24 hours. HDL was isolated by ultracentrifugation and analyzed for cholesterol content. HDL treated with dipalmitory lecithin without free cholesterol addition was used as control HDL. n=3 per group with duplicate measurements; B to D, Incorporation of free cholesterol into normal HDL effects loss of HDL activity on glucocorticoid-induced thymocyte apoptosis. Thymocytes from wild-type mice were cultured in complete medium and incubated with/without 10 μmol/L corticosterone for 18 hours in the presence/absence of HDL (20% vol/vol) enriched with free cholesterol (0.149±0.003 mg/mL by protein) or control HDL (0.119±0.010 mg/mL by protein). The cell death was analyzed by 7-aminoactinomycin D staining (B and C) and Trypan blue assays (D). HDL treated with dipalmitoyl lecithin without free cholesterol addition was used as control HDL. n=3 with duplicate measurements. demonstrate that SR-BI is a key determinant and HDL is a critical modulator of thymocyte apoptosis in sepsis.
SR-BI-Mediated iGC Production by Adrenals Is a Determinant of Thymocyte Apoptosis in Sepsis
Thymocyte apoptosis is a major event in sepsis; however, how this process is regulated remains poorly understood. Glucocorticoids are potent triggers of thymocyte apoptosis. [2] [3] [4] Their generation is regulated by 3 major factors: (1) availability of intracellular cholesterol, (2) transport of cholesterol to mitochondria, and (3) enzymes that convert cholesterol to glucocorticoid. The organ with the highest SR-BI expression is the adrenal. 8 As an HDL receptor, SR-BI takes up cholesteryl ester from HDL to provide cholesterol for glucocorticoid synthesis in the adrenals. 42 The fact that SR-BI −/− mice are completely deficient in iGC production in response to septic stress indicates that the SR-BI-mediated cholesteryl ester uptake from HDL is a rate-limiting step for iGC production. Of note, mouse mainly has HDL, but human has both low-density lipoprotein (LDL) and HDL. This raises a possibility that human may use LDL-LDL receptor pathway as a source of cholesterol for glucocorticoid synthesis in addition to HDL-SR-BI pathway. However, patients with homozygous familial hypercholesterolemia (LDL receptor null) displayed normal iGC production in response to a single dose of adrenocorticotropic hormone. 43 Furthermore, heterozygous carriers of LDL receptor mutations displayed normal glucocorticoid production, 44 but patients with mutant SR-BI (≈50% reduction in SR-BImediated cholesterol uptake activity) had ≈50% reduction in glucocorticoid production in response to a single dose of adrenocorticotropic hormone. 45 These studies suggest that the SR-BI-mediated cholesteryl ester uptake from HDL is likely a rate-limiting step for iGC production in humans in sepsis.
HDL Is a Critical Modulator of Glucocorticoid-Induced Thymocyte Apoptosis
When we administered glucocorticoid to SR-BI −/− mice, we unexpectedly found that supplementation of dexamethasone only partly restored thymocyte apoptosis in SR-BI −/− mice. This implies that SR-BI modulates thymocyte apoptosis via a secondary mechanism in addition to controlling iGC generation.
By excluding intrinsic effect of SR-BI, we tested our hypothesis that HDL is a modulator of glucocorticoid-induced thymocyte apoptosis and that SR-BI modulates glucocorticoid-induced thymocyte apoptosis through HDL. Our findings suggest that HDL profoundly enhances glucocorticoid-induced thymocyte apoptosis likely through promoting glucocorticoid-induced GR translocation. Interestingly, HDL from SR-BI −/− mice lost this regulatory function. Importantly, human HDL significantly enhanced glucocorticoid-induced thymocyte apoptosis. To determine the importance of HDL in modulating thymocyte apoptosis in vivo, we used apoAI −/− mice that are grossly deficient in HDL. As expected, mice deficient in HDL displayed impaired thymocyte apoptosis in sepsis, supporting our hypothesis.
Accumulation of Unesterified Cholesterol on SR-BI −/− HDL Renders It Dysfunctional
Nascent HDL acquires free cholesterol from peripheral tissues, and LCAT catalyzes the free cholesterol to form cholesteryl ester, which is a critical step for HDL metabolism. Interestingly, an earlier study showed that SR-BI −/− mice have a 90% decrease in endogenous LCAT activity in HDL. 20 Thus, it is plausible that SR-BI −/− HDL would accumulate unesterified cholesterol because of the lack of LCAT activity. Indeed, in agreement with earlier reports, [18] [19] [20] we observed a 3-fold increase in unesterified cholesterol contents of SR-BI −/− HDL compared with SR-BI +/+ HDL, but the cholesteryl ester levels of SR-BI −/− HDL were only minimally elevated compared with SR-BI +/+ HDL. Based on the difference in hydrophobic nature between unesterified cholesterol and cholesteryl ester, 22 we proposed that SR-BI −/− HDL loses its regulatory activity on glucocorticoid-induced thymocyte apoptosis because of disruption of HDL structure as a result of the accumulation of unesterified cholesterol on the surface of HDL. To test this hypothesis, we took 3 independent approaches. First, we administered probucol to SR-BI −/− mice. Probucol normalized the unesterified cholesterol level of SR-BI −/− HDL; importantly, probucol effectively restored glucocorticoid-induced thymocyte apoptosis both in vivo and in vitro. Second, we incorporated free cholesterol to SR-BI +/+ HDL. We found that this free cholesterol-enriched HDL loses its ability to promote glucocorticoid-induced thymocyte apoptosis. Finally, we isolated HDL from SR-BI −/− LCAT-tg mice. The overexpression of LCAT in SR-BI −/− mice normalized the unesterified cholesterol contents in HDL and partly restored the activity of HDL on glucocorticoid-induced thymocyte apoptosis.
Although clinical studies have clearly established a negative correlation between plasma HDL cholesterol levels and cardiovascular diseases, 46, 47 there is growing appreciation that elevation in A and B) , n=6 each group. Survival was monitored for 7 days and analyzed with log-rank χ 2 (C). lckCre-GR fl/fl (n=13) and GR fl/fl (n=8) littermates. NS indicates not significant.
HDL cholesterol levels may not always be beneficial and may even be deleterious. [48] [49] [50] [51] Indeed, SR-BI −/− mice have a 2-fold increase in plasma HDL cholesterol concentrations, but are susceptible to atherosclerosis and other cardiovascular diseases, [12] [13] [14] [15] [16] suggesting that a defect in SR-BI-mediated HDL metabolism may render HDL dysfunctional. Here, using 3 independent approaches, we demonstrated that the massive accumulation of unesterified cholesterol on SR-BI −/− HDL likely accounts for loss of its regulatory activity on glucocorticoid-induced thymocyte apoptosis. Just as massive accumulation of unesterified cholesterol on HDL likely disrupts the structure of HDL, it may also impair the other functions of HDL, such as the selective cholesteryl ester uptake. Further study is warranted to test this speculation.
Glucocorticoid-GR Signaling in Thymocytes/T Cells Is Required for Protection Against CLP-Induced Septic Death
As opposed to normal physiological conditions in which only ≈1% of thymocytes undergo apoptosis, in sepsis, thymocyte apoptosis is increased by 10-to 20-fold, which indicates a marked increase in thymocyte stress during sepsis. Whether this massive apoptotic cell death is simply a passive response to septic stress or a protective mechanism remains an open question. Using lckCre-GR fl/fl mice in which thymocytes lack the GR, Mittelstadt et al 52 demonstrated that glucocorticoid-GR signaling is required for proper selection of thymocytes and absence of glucocorticoid-GR signaling in thymocytes impairs thymocyte development, resulting in generation of functionally compromised T cells. Considering that thymocyte apoptosis is a major mechanism of thymocyte selection, we speculate that SR-BI and HDL-regulated glucocorticoid-GR signaling is required for the removal of the stressed thymocytes and a failure in this process impairs the development of thymocytes, resulting in functionally compromised T cells. We conducted CLP on lckCre-GR fl/fl mice. The lckCre-GR fl/fl mice were completely resistant to CLP-induced thymocyte apoptosis and significantly more susceptible to CLP-induced septic death compared with GR fl/fl littermates, which supports our hypothesis.
In summary, this study identifies SR-BI and HDL as key regulators of glucocorticoid-GR signaling in thymocytes in sepsis. As shown in Figure VI in the online-only Data Supplement, (1) in adrenals, SR-BI mediates the production of iGC which induces thymocyte apoptosis; (2) in thymus, HDL enhances glucocorticoid-induced thymocyte apoptosis likely via promoting GR nuclear relocation; (3) lack of SR-BImediated reverse cholesterol transport in liver causes accumulation of free cholesterol on HDL that renders it inactive on thymocyte apoptosis; and (4) the SR-BI and HDL-regulated glucocorticoid-GR signaling is likely required for removal of stressed thymocytes, proper selection of thymocyte, and protection against sepsis.
